Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Comment from Internationella Engelska Skolan’s independent bid committee in relation to the mandatory public offer from Grundstenen 300029

On the 25th of September 2020, Grundstenen 300029 AB (the “Bidder”), owned by a consortium led by Paradigm Capital Value Fund SICAV, as well as Paradigm Capital Value LP, The Hans and Barbara Bergström Foundation, AB Tuna Holding, certain investors which are advised by Paradigm Capital AG (investment advisor to Paradigm Capital SICAV) and certain investors who have previously not been shareholders of IES (the “Consortium”), announced a mandatory public offer, in which the Bidder offers SEK 77.04 in cash for each share of Internationella Engelska Skolan i Sverige Holdings II AB (publ) (”IES”)

Purchase of treasury shares

Reference is made to Ocean Yield ASA’s (“Ocean Yield” or “Company”) stock exchange notice on 24 September 2020 where the Company announced its intention to purchase up to 100,000 treasury shares in connection with its incentive scheme for employees. Ocean Yield has on 25 September 2020 purchased 50,000 shares in the Company on Oslo Stock Exchange at an average price of NOK 21.99 per share, which implies a total consideration of NOK 1,099,740. The purchase of treasury shares was carried out in accordance with an authorization granted by the Annual General Meeting of the Company on 22 April

Nomination Committee for ÅF Pöyry AB (publ) appointed

The following members have, in accordance with the procedure adopted by the Annual General Shareholders Meeting, been appointed to the ÅF Pöyry Nomination Committee. Magnus Olofsson, (Chairman of the Nomination Committee) appointed by Stiftelsen ÅForsk Elisabet Jamal Bergström, appointed by SEB Investment Management Lilian Fossum Biner, appointed by Handelsbanken Fonder Monica Åsmyr, appointed by Swedbank Robur Fonder Niklas Ringby, appointed by EQT Public Value Anders Narvinger, Chairman of the Board Shareholders proposals to the nomination committee should be

aXichem presents its natural analogue capsaicin aXivite, together with new marketing material, in series of webinars

aXichem AB (publ), a developer of natural analogue industrial compounds, has published new marketing material describing the features and benefits of its product aXivite, targeting the neutraceutical and food supplement market. aXIchem will be hosting a series of webinars open for potential customers and industry partners. - Yesterday we had the pleasure to host aXichem’s first industry webinar. Since basically all conferences and meetings are cancelled, due to the pandemic, this is an excellent way to meet the market’s interest. To support the event we have produced some new marketing

Minutes of Kværner ASA’s Extraordinary General Meeting 25 September 2020

25 September 2020 - The Extraordinary General Meeting of Kværner ASA was held today, 25 September 2020 at Snarøyveien 20, 1360 Fornebu, Norway. All proposals on the agenda were adopted, including approval of the merger plan dated 17 July 2020 regarding the contemplated merger with Aker Solutions ASA (the “Merger”). Please refer to previous stock exchange notices published by Kværner ASA and the Exempted Document dated 4 September 2020 for more information regarding the Merger. Minutes for Extraordinary General Meeting 2020 is attached to this release and are published on www.kvaerner.

NPRO: Successful placement of new secured bond

Reference is made to the notification dated 24 September 2020. Norwegian Property ASA has today issued a new NOK 500 million secured bond with a tenor of 5 years and with a floating interest rate of 3 months NIBOR + 1.37% p.a. The proceeds will be used for refinancing of the bond NPRO12 with maturity date 9. November 2020 and general corporate purposes. SEB acted as Sole Manager for the bond issuance. For further information please contact Haavard Rønning (CFO) tel +(47) 400 20 019

World’s first hydrogen-electric flight of a commercial airplane uses fuel cell system from PowerCell Sweden

When UK-based Zero Avia yesterday conducted a flight with a single-engine six-seater powered by its hydrogen-electric powertrain, a PowerCell MS-100 fuel cell system was an integral part of the powertrain. The flight was the world’s first flight with a commercial single engine aircraft powered by a hydrogen fuel cell.“This proves that fuel cells and hydrogen is a well-functioning and real-world solution for more sustainable flying which will be crucial for a successful handling of the climate crisis”, Karin Nilsson, acting CEO of PowerCell Sweden said.   The maiden flight took place

MyControl - A new website to raise awareness about obesity among healthcare professionals and patients

Today, Navamedic launches MyControl – a new website targeted towards both the general public & healthcare professionals to raise awareness about obesity and its treatments.This is the first step in a wave of communication as part of Navamedic’s effort to increase knowledge about obesity, and to address the fact that obesity is a disease and hence should be treated as one. “This is a milestone in our attempt to highlight the complexity surrounding this disease and the treatment options available. This is still an underdiagnosed area and we are committed to putting it on the agenda among

Nomination Committee of AB SKF for the Annual General Meeting 2021

Gothenburg, 25 September 2020: In accordance with a resolution taken at the Annual General Meeting of AB SKF on 26 March 2020, this is to announce, due to changes of the four largest shareholders by number of votes, the representatives who, together with the Chairman of the Board, constitute the Nomination Committee in preparation of the Annual General Meeting 2021.  Representatives:Marcus Wallenberg, FAM Anders Jonsson, Skandia  Anders Algotsson, AFA Försäkring Evert Carlsson, Swedbank Robur Fonder The Annual General Meeting of AB SKF will be held in Gothenburg on Thursday,

Norwegian Police buildings to be secured by Caverion

Caverion Corporation Investor news 25 September 2020 at 4.00 p.m. EESTNorwegian Police buildings to be secured by CaverionTechnology provided by Caverion will secure buildings for the Norwegian Police through a framework agreement with the Norwegian Police Shared Services (PFT). Caverion is providing, installing and maintaining security systems for the PFT including access control, video surveillance and security alarm systems.  “The providers were assessed on quality, price and security understanding, and Caverion is the preferred supplier with the highest overall score of the

Nustay A/S: Update on financial situation

Nustay A/S (“Nustay” or “the Company”) hereby announces that the Company does not have sufficient capital to sustain operations for at least three months. Currently, Nustay estimates that it has funds that will be sufficient for approximately one  month. The Company is working intensively to explore different alternatives to secure financing. Nustay cannot, however, make any precise estimates in terms of its capital need, as this is dependent on potential future revenue, which is difficult to forecast in light of the ongoing Covid-19 pandemic. The situation has arised as a result of the

Hamlet Pharma Starts Two Parallel Clinical Study Programs

Hamlet Pharma is pleased to announce that the clinical development of Alpha1H therapy in bladder cancer will be accelerated. Two studies will be conducted in parallel; a dose-escalation study, which will examine the efficacy of higher Alpha1H concentrations and a combination study, combining Alpha1H with a currently used chemotherapeutic agent.Today Hamlet Pharma has received the permission from the Czech authorities to resume its clinical trial activities, together with the team in Prague. The dose-escalation and combination therapy studies will both be conducted, simultaneously. There

Calmark decides to locate the Chinese subsidiary in Guangzhou, Greater Bay Area

An exploratory review has led Calmark to the conclusion that the Greater Bay Area will be the most suitable location for Calmark's subsidiary in mainland China. The city of Guangzhou, situated as it is and harboring a cluster of MedTech companies, has now been selected for the next phase.On behalf of Calmark, the consultancy firm Nordic Match has reviewed ten different areas in China and compared their respective access to talents, FTZ (foreign trade zones), industrial clusters and logistics opportunities. The city of Guangzhou, with 15.3 million inhabitants, functions as a hub for both

Bioservo signs distribution agreement with Tecno Italia

Bioservo Technologies AB has signed a distribution agreement with Tecno Italia Srl. for selling Ironhand® in Italy. Tecno Italia specializes in fastening solutions for companies within manufacturing and assembly, including some of the largest automotive companies in Italy. They act as a partner providing solutions for all needs relating to fastening, from the design of single workstations to the management of specific plant reporting. By providing a wide range of products they are able to deliver complete solutions including workflow optimization and improved ergonomics for operator

The collectables funds showed increase of value during the first half of 2020 despite lockdown of operations during the pandemic - Amendment

Numisbing AB (publ) reports to NAV * on three classes of funds in which Numisbing AB (publ) continues to invest. There are three different classes of Collectibles Funds with separate portfolio funds. During the first half of 2020, NAV increased in percentage terms on a full year basis in the various classes with the following results.Class A +1.7%, Class B + 1.19%, Class C + 0.68%.The fund showed the following increase in value since the beginning of 2018:Class A +66.67%, Class B + 64.18%, Class C + 61.08%.The fund’s growth during the first half of 2020 was not as strong as

Biohit GastroPanel[®] test was studied clinically in patients with autoimmune disease

Press release 25.09.2020 at 15.00 local time (EEST)   This study was completed at the Outpatient Department of Internal Medicine (Oulu University Hospital), and the report of the results was recently accepted for publication in an international gastroenterology journal (1).  At the moment endoscopic services have been severely curtailed due to the COVID-19 pandemic. This further increases the risk of patients with autoimmune disease developing autoimmune atrophic gastritis (AAG) and even gastric cancer before diagnosis can be made. Biohit´s solution is to use the GastroPanel[®]

Lehto Group Plc: Resolutions of Lehto Group Plc’s Extraordinary General Meeting 2020

Lehto Group PlcResolutions of Lehto Group Plc's Extraordinary General Meeting25 September 2020 at 15.00 (EET)The Extraordinary General Meeting of shareholders of Lehto Group Plc took place in Kempele (address Voimatie 6) on 25 September 2020. The Extraordinary General Meeting did the following resolutions: The Extraordinary General Meeting authorised the Board of Directors to resolve on the issuance of a maximum of 60,000,000 new shares to carry-out the rights issue. With the share issue, the company wants to strengthen its ability to implement the strategy and further develop

Invitation – Orexo Digital Therapeutics business update October 1

Uppsala, Sweden – September 25, 2020 – Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY) today invites investors, analysts, and media to attend a teleconference on Thursday October 1, at 3 pm CET. During the event, Orexo will provide an update on the company’s Digital Therapeutics business, and discuss clinical data demonstrating efficacy for both deprexis® and vorvida®, Orexo’s recently launched digital therapies in the US, and ongoing activities relating to commercialisation and marketing. Orexo will also provide an update on market access strategies and its technical platform offering,

Minutes of Kværner ASA’s Extraordinary General Meeting 25 September 2020

25 September 2020 - The Extraordinary General Meeting of Kværner ASA was held today, 25 September 2020 at Snarøyveien 20, 1360 Fornebu, Norway. All proposals on the agenda were adopted, including approval of the merger plan dated 17 July 2020 regarding the contemplated merger with Aker Solutions ASA (the “Merger”). Please refer to previous stock exchange notices published by Kværner ASA and the Exempted Document dated 4 September 2020 for more information regarding the Merger. Minutes for Extraordinary General Meeting 2020 is attached to this release and are published on www.kvaerner.com.

Company Announcement No. 89, 2020 - Fixing of coupons with effect as from 1 October 2020

The coupons for the Capped floaters listed below will be changed taking effect 1 October 2020. The new coupons will be in force from 1 October 2020 – 31 March 2021. Capped floater with a 5 per cent interest rate cap, CF DK0002015106, maturity 2038, new coupon as per 1 October 2020:   0.74% p.a. Capped floater with a 5 per cent interest rate cap, CF OADK0002015296, maturity 2038, new coupon as per 1 October 2020:   0.74% p.a. Capped floater with a 6 per cent interest rate cap, CFDK0002021427, maturity 2041, new coupon as per 1 October 2020:   0.39% p.a. Capped floater with

A genetic variant that protects against Alzheimer’s disease promotes immune cell functions

A new study conducted by researchers at the University of Eastern Finland found that the PLCG2-P522R genetic variant, which protects against Alzheimer’s disease, enhances several key functions of immune cells. The results obtained in the study highlight the importance of immune cells as a target of future development of new therapies for Alzheimer’s disease.Alzheimer’s disease is the most common form of dementia with more than 40 million affected people worldwide. To this day, there are no existing therapies for the effective prevention or treatment of the disease. Many recently identified

Dispelix strengthens its board with the appointments of Markku Hirvonen and Thomas Alt

Dispelix Oy, the technology leader in see-through augmented reality (AR) displays, is pleased to announce two new strategic appointments to its board of directors. Markku Hirvonen has been appointed as Executive Chairman of the Board, while Thomas Alt will become a member of the board. Markku Hirvonen has over 30 years’ experience in the high-tech sector, having held roles with several leading national and international companies including Nokia and Fujitsu Siemens Computers. He also served as President and CEO of VTI Technologies (now Murata Electronics). Markku brings considerable

Aker Solutions ASA: Minutes From Extraordinary General Meeting

September 25, 2020 - Aker Solutions ASA today held an extraordinary general meeting at the company's headquarters in Fornebu, Norway.All proposals on the agenda were adopted, including approval of the merger plan dated July 17, 2020 regarding the contemplated merger with Kværner ASA (the “Merger”). For more information regarding the Merger, please see previous stock exchange releases published by Aker Solutions ASA and the Exempted Document dated September 4, 2020. The general meeting also elected a new board of directors with effect from the date of completion of the merger. The new

The collectibles funds had increase in their value during the first half of 2020 despite the closure of operations during the pandemic

Numisbing AB (publ) reports to NAV * on three classes of funds in which Numisbing AB (publ) continues to invest. There are three different classes of Collectibles Fund with separate portfolio funds. During the first half of 2020, NAV increased in percentage terms on a full-year basis in the various classes with the following results. Class A +1.7%, Class B + 1.19%, Class C + 0.68%. The fund has increased the following in value since the start from 2018: Class A +66.67%, Class B + 64.18%, Class C + 61.08%.It is not the same large positive development of the fund during the first

There are no items matching the current filter
There are no more items matching the current filter
Back to top